title: [Systemic lupus erythematosus during therapy with oral estrogen-progestin. Considerations apropos of a case].
authors.forename: N
authors.initials: N
authors.lastname: Gueli
authors.forename: A
authors.initials: A
authors.lastname: Toto
authors.forename: E
authors.initials: E
authors.lastname: Tartaglione
authors.forename: M C
authors.initials: MC
authors.lastname: Lucianetti
authors.forename: M
authors.initials: M
authors.lastname: Screnci
authors.forename: V
authors.initials: V
authors.lastname: Sauli
authors.forename: G
authors.initials: G
authors.lastname: Carmenini
mesh_terms: D000328:Adult; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D004997:Ethinyl Estradiol / Q000009:adverse effects*; D019304:Ethinyl Estradiol-Norgestrel Combination; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D009644:Norgestrel / Q000009:adverse effects*; D011282:Pregnenediones / Q000627:therapeutic use
chemical_list: D003278:Contraceptives, Oral, Hormonal; D011282:Pregnenediones; D009644:Norgestrel; D004997:Ethinyl Estradiol; D019304:Ethinyl Estradiol-Norgestrel Combination; C021988:deflazacort
vernacular_title: Lupus eritematoso sistemico in corso di terapia con estroprogestinici orali. Considerazioni a proposito di un caso.